Physician

Helen Filo Tergin, MD

According to 2025 Medicare claims, Helen Tergin, MD (NPI: 1578540571) practices dermatology in the Columbia, MO market, with the plurality of this provider's patient population coming from Boone, MO. This provider's primary affiliated billing organization is CENTRAL MISSOURI DERMATOLOGY ASSOCIATES, LLP (NPI: 1447669932; TIN: 463133783) and primary practice location at 65201-6625.

Tergin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,141 traditional Medicare patients, billed 6,618 HCPCS/CPT codes, and received $252,669 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 551 prescription claims across 204 beneficiaries totaling $98,327 in drug costs, led by Metronidazole (Metronidazole). Open Payments data shows 51 records totaling $885. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $47,716 to $252,669. Similarly, Part D prescription costs have risen steadily, from $24,535 to $98,327. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$151K$303K2015 Medicare payment: $47,716 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $165,021 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $143,428 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $256,918 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $291,481 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $251,283 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $272,134 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $289,677 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $302,636 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $252,669 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152781,088$47,716
20165853,904$165,021
20175963,589$143,428
20188337,314$256,918
20198557,315$291,481
20207726,395$251,283
20218026,972$272,134
20229357,016$289,677
20231,1007,315$302,636
20241,1416,618$252,669

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$66K$132K2015 Drug cost: $24,535 (USD; Tot_Drug_Cst)2016 Drug cost: $87,386 (USD; Tot_Drug_Cst)2017 Drug cost: $53,252 (USD; Tot_Drug_Cst)2018 Drug cost: $29,676 (USD; Tot_Drug_Cst)2019 Drug cost: $86,946 (USD; Tot_Drug_Cst)2020 Drug cost: $131,508 (USD; Tot_Drug_Cst)2021 Drug cost: $109,720 (USD; Tot_Drug_Cst)2022 Drug cost: $106,562 (USD; Tot_Drug_Cst)2023 Drug cost: $111,750 (USD; Tot_Drug_Cst)2024 Drug cost: $98,327 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015149295$24,535
2016196569$87,386
2017173499$53,252
2018239578$29,676
2019246596$86,946
2020237596$131,508
2021240572$109,720
2022214480$106,562
2023212472$111,750
2024204551$98,327

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths217254$67
11102Biopsy of related skin growth, first growth539682$54
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8881,223$52
17000Destruction of precancer skin growth, 1 growth661948$30
17003Destruction of precancer skin growth, 2-14 growths4642,137$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MetronidazoleMetronidazole28906$2,007
KetoconazoleKetoconazole712,036$1,412
Doxycycline HyclateDoxycycline Hyclate662,174$1,039
Clobetasol PropionateClobetasol Propionate24975$909
Clindamycin PhosphateClindamycin Phosphate17675$673

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.51$885ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Helen Filo Tergin, MD?

Tedicare shows public-source Medicare data for Helen Filo Tergin, MD (NPI 1578540571), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Helen Filo Tergin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Helen Filo Tergin, MD?

Helen Filo Tergin, MD is linked to CENTRAL MISSOURI DERMATOLOGY ASSOCIATES, LLP (billing NPI 1447669932) in the available physician profile data.

Does Helen Filo Tergin, MD have Open Payments data?

Helen Filo Tergin, MD has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.